Friday, December 9, 2016

My NEW Pick is Pegasus Pharmaceuticals (PGUZ). It's cutting edge patented technology named the HeartVue™ 6S System allows for the non-invasive screening of heart disease. Incredibly the technology provides a 3d portrait of the heart in just 60 seconds. This is a huge game changer and the CEO has confirmed that they are now working with some big pharmaceutical companies, 2 are believed to be German based Bayer AG and US based Bristol Meyers-Squibb (BMY), both who have invested heavily in non-invasive screening for heart pathologies. With marketing already happening in Europe the company now has filed with the FDA for approval in the US. This stock is under the radar trading sub penny but that won't last long, the CEO has hinted at big news and stated he will be providing updates shortly, NOW is the time to buy before this tiny biotech gets discovered, they could become the biggest gainer of 2016!

Most of our publisher picks rise 100%, 200% or more once they hit the front page of our blog. Get some, sit back and enjoy the ride! 

**Our Latest Publisher Pick is  Pegasus Pharmaceuticals (PGUZ), the most undervalued biotech stock out there**

With over 1.5 million visitors to our blogs and thousands of visitors daily, Sierra World Equity Review will be giving MASSIVE MULTIPLE DAY targeted audience exposure to our latest Publisher Alert: Pegasus Pharmaceuticals (PGUZ)


Here is why our Publisher has initiated a  position in Pegasus Pharmaceuticals (PGUZ)

My NEW Pick is Pegasus Pharmaceuticals (PGUZ). It's cutting edge patented technology named the HeartVue™ 6S System allows for the non-invasive screening of heart disease. Incredibly the technology provides a 3d portrait of the heart in just 60 seconds. This is a huge game changer and the CEO has confirmed that they are now working with some big pharmaceutical companies,  2 are believed to be German based Bayer AG and US based Bristol Meyers-Squibb (BMY), both who have invested heavily in non-invasive screening for heart pathologies. With marketing already happening in Europe the company now has filed with the FDA for approval in the US. This stock is under the radar trading sub penny but that won't last long, the CEO has hinted at big news and stated he will be providing updates shortly, NOW is the time to buy before this tiny biotech gets discovered, they could become the biggest gainer of 2016!




My NEW Pick is a small biotech company called Pegasus Pharmaceuticals (PGUZ). They look like they could become the biggest gainer of the year, trading now in sub-penny range but likely to ink a partnership or even be acquired by one of the two big pharmaceutical company they are currently working with. Now is the time to buy shares of PGUZ, don't get left behind!

Pegasus Pharmaceuticals (PGUZ)  Highlights:

- An amazing share structure of just 21.6M O/S
- A float of just 5M
- Insiders own over half the float and they are NOT SELLING
-Patented game changing, revenue generating cutting edge technology that is desired by big Pharma
-CEO confirmed the company is working with some big Pharma's ( 2 of which are believed to be German based Bayer AG and US based Bristol Meyers-Squibb (BMY)
-Massive revenue potential, considering that in the US alone annually, approximately 635,000 Americans experience a new coronary event, 280,000 have a recurrent ischemic event, and an additional 150,000 have a silent first myocardial infarction. The ability to easily diagnosis heart disease will not only save countless lives but be incredibly lucrative, especially since the technology is patented by Pegasus Pharmaceuticals (PGUZ)


About Pegasus Pharmaceuticals (PGUZ)  

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities


***BE FIRST TO RECEIVE DarthTraderWins WINNING PICKS ON TWITTER***


About Sierra

Hi, my name is Sierra and I'm 27 yrs old. I'm single and I live in Old Town in beautiful Key West, Florida. Thanks to a family inheritance I feel very blessed and fortunate to be financially independent allowing me to live life to the fullest!
Apart from the stock market my favorite things to do are mostly beach related, I love surfing and spend months of the year travelling to different surfing hot spots worldwide chasing the next big wave. When I'm not in the water you can find me playing beach volleyball, enjoying happy hour with friends or dancing the night away! 

Paddling out for the next wave!                                                                                 credit: juancap3q Tumblr


If you are in Key West stop by and say hi to me, if I'm not out of town it's likely I'll be at Sloppy Joes or The Schooner Wharf Bar once the sun goes down! I love to make new friends and men please do not be intimidated by my looks, I do not bite! Dance, be happy, enjoy life and good luck in all your trades!

Sierra World Equity Review

Independent and uncompensated! Sierra World Equity Review and it's publisher have never been compensated to promote any stock. We are not affiliated with any executives, owners, brokers, promoters or analysts. The publisher of Sierra World Equity Review is not a registered investment adviser, before making a purchase or sale of any securities featured on this site, we strongly recommend consultation with a registered securities representative. Please remember to do your own due diligence in regards to any stocks that appear on our websites, never trade securities based on Sierra's speculations or predictions! Please read our disclaimer and privacy policy below.

Dot the I's and Cross the T's_Pfizer (PFE) Ceo Ian Read to announce the acquisition of Immune Pharmaceuticals (IMNP) at an official Press Conference at Pfizer HQ in NYC tentatively scheduled for this coming Wednesday anticipates Sierra World Equity Review

Dot the I's and Cross the T's_Pfizer (PFE) Ceo Ian Read to announce the acquisition of Immune Pharmaceuticals (IMNP) at an official Press Conference at Pfizer HQ in NYC tentatively scheduled for this coming Wednesday anticipates Sierra World Equity Review. Shares of IMNP were trading 10% higher at the close of Friday's session! Sierra is still being briefed by aides Adam and Jonny on the terms of the deal, check back for the latest! Remember when the news breaks, Sierra told you first!

Most of our publisher picks rise 100%, 200% or more once they hit the front page of our blog. Get some, sit back and enjoy the ride! 


**Our Latest Publisher Pick is  Pegasus Pharmaceuticals (PGUZ), the most undervalued biotech stock out there**


With over 1.5 million visitors to our blogs and thousands of visitors daily, Sierra World Equity Review will be giving MASSIVE MULTIPLE DAY targeted audience exposure to our latest Publisher Alert: Pegasus Pharmaceuticals (PGUZ)



Here is why our Publisher has initiated a  position in Pegasus Pharmaceuticals (PGUZ)

My NEW Pick is Pegasus Pharmaceuticals (PGUZ). It's cutting edge patented technology named the HeartVue™ 6S System allows for the non-invasive screening of heart disease. Incredibly the technology provides a 3d portrait of the heart in just 60 seconds. This is a huge game changer and the CEO has confirmed that they are now working with some big pharmaceutical companies,  2 are believed to be German based Bayer AG and US based Bristol Meyers-Squibb (BMY), both who have invested heavily in non-invasive screening for heart pathologies. With marketing already happening in Europe the company now has filed with the FDA for approval in the US. This stock is under the radar trading sub penny but that won't last long, the CEO has hinted at big news and stated he will be providing updates shortly, NOW is the time to buy before this tiny biotech gets discovered, they could become the biggest gainer of 2016!




My NEW Pick is a small biotech company called Pegasus Pharmaceuticals (PGUZ). They look like they could become the biggest gainer of the year, trading now in sub-penny range but likely to ink a partnership or even be acquired by one of the two big pharmaceutical company they are currently working with. Now is the time to buy shares of PGUZ, don't get left behind!

Pegasus Pharmaceuticals (PGUZ)  Highlights:

- An amazing share structure of just 21.6M O/S
- A float of just 5M
- Insiders own over half the float and they are NOT SELLING
-Patented game changing, revenue generating cutting edge technology that is desired by big Pharma
-CEO confirmed the company is working with some big Pharma's ( 2 of which are believed to be German based Bayer AG and US based Bristol Meyers-Squibb (BMY)
-Massive revenue potential, considering that in the US alone annually, approximately 635,000 Americans experience a new coronary event, 280,000 have a recurrent ischemic event, and an additional 150,000 have a silent first myocardial infarction. The ability to easily diagnosis heart disease will not only save countless lives but be incredibly lucrative, especially since the technology is patented by Pegasus Pharmaceuticals (PGUZ)


About Pegasus Pharmaceuticals (PGUZ)  

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities


***BE FIRST TO RECEIVE DarthTraderWins WINNING PICKS ON TWITTER***



About Sierra

Hi, my name is Sierra and I'm 27 yrs old. I'm single and I live in Old Town in beautiful Key West, Florida. Thanks to a family inheritance I feel very blessed and fortunate to be financially independent allowing me to live life to the fullest!
Apart from the stock market my favorite things to do are mostly beach related, I love surfing and spend months of the year travelling to different surfing hot spots worldwide chasing the next big wave. When I'm not in the water you can find me playing beach volleyball, enjoying happy hour with friends or dancing the night away! 

Paddling out for the next wave!                                                                                 credit: juancap3q Tumblr


If you are in Key West stop by and say hi to me, if I'm not out of town it's likely I'll be at Sloppy Joes or The Schooner Wharf Bar once the sun goes down! I love to make new friends and men please do not be intimidated by my looks, I do not bite! Dance, be happy, enjoy life and good luck in all your trades!

Sierra World Equity Review

Independent and uncompensated! Sierra World Equity Review and it's publisher have never been compensated to promote any stock. We are not affiliated with any executives, owners, brokers, promoters or analysts. The publisher of Sierra World Equity Review is not a registered investment adviser, before making a purchase or sale of any securities featured on this site, we strongly recommend consultation with a registered securities representative. Please remember to do your own due diligence in regards to any stocks that appear on our websites, never trade securities based on Sierra's speculations or predictions! Please read our disclaimer and privacy policy below.

DryShips, Inc. (DRYS) CEO Mr. George Economou to schedule Press Conference early next week announcing acquisition deal with Japanese shipping company Nippon Yusen Kabushiki Kaisha NYK anticipates Sierra World Equity Review

DryShips, Inc. (DRYS) CEO Mr. George Economou to schedule Press Conference early next week announcing acquisition deal with Japanese shipping company Nippon Yusen Kabushiki Kaisha NYK anticipates Sierra World Equity Review. Watch for breaking news, shares of DRYS closed slightly lower down 5% at the end of Friday's session. Sierra is hoping to conduct a live SKYPE interview with Mr Economou following the press conference.Check back for times and dates.

Most of our publisher picks rise 100%, 200% or more once they hit the front page of our blog. Get some, sit back and enjoy the ride! 


**Our Latest Publisher Pick is  Pegasus Pharmaceuticals (PGUZ), the most undervalued biotech stock out there**


With over 1.5 million visitors to our blogs and thousands of visitors daily, Sierra World Equity Review will be giving MASSIVE MULTIPLE DAY targeted audience exposure to our latest Publisher Alert: Pegasus Pharmaceuticals (PGUZ)



Here is why our Publisher has initiated a  position in Pegasus Pharmaceuticals (PGUZ)

My NEW Pick is Pegasus Pharmaceuticals (PGUZ). It's cutting edge patented technology named the HeartVue™ 6S System allows for the non-invasive screening of heart disease. Incredibly the technology provides a 3d portrait of the heart in just 60 seconds. This is a huge game changer and the CEO has confirmed that they are now working with some big pharmaceutical companies,  2 are believed to be German based Bayer AG and US based Bristol Meyers-Squibb (BMY), both who have invested heavily in non-invasive screening for heart pathologies. With marketing already happening in Europe the company now has filed with the FDA for approval in the US. This stock is under the radar trading sub penny but that won't last long, the CEO has hinted at big news and stated he will be providing updates shortly, NOW is the time to buy before this tiny biotech gets discovered, they could become the biggest gainer of 2016!




My NEW Pick is a small biotech company called Pegasus Pharmaceuticals (PGUZ). They look like they could become the biggest gainer of the year, trading now in sub-penny range but likely to ink a partnership or even be acquired by one of the two big pharmaceutical company they are currently working with. Now is the time to buy shares of PGUZ, don't get left behind!

Pegasus Pharmaceuticals (PGUZ)  Highlights:

- An amazing share structure of just 21.6M O/S
- A float of just 5M
- Insiders own over half the float and they are NOT SELLING
-Patented game changing, revenue generating cutting edge technology that is desired by big Pharma
-CEO confirmed the company is working with some big Pharma's ( 2 of which are believed to be German based Bayer AG and US based Bristol Meyers-Squibb (BMY)
-Massive revenue potential, considering that in the US alone annually, approximately 635,000 Americans experience a new coronary event, 280,000 have a recurrent ischemic event, and an additional 150,000 have a silent first myocardial infarction. The ability to easily diagnosis heart disease will not only save countless lives but be incredibly lucrative, especially since the technology is patented by Pegasus Pharmaceuticals (PGUZ)


About Pegasus Pharmaceuticals (PGUZ)  

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities


***BE FIRST TO RECEIVE DarthTraderWins WINNING PICKS ON TWITTER***



About Sierra

Hi, my name is Sierra and I'm 27 yrs old. I'm single and I live in Old Town in beautiful Key West, Florida. Thanks to a family inheritance I feel very blessed and fortunate to be financially independent allowing me to live life to the fullest!
Apart from the stock market my favorite things to do are mostly beach related, I love surfing and spend months of the year travelling to different surfing hot spots worldwide chasing the next big wave. When I'm not in the water you can find me playing beach volleyball, enjoying happy hour with friends or dancing the night away! 

Paddling out for the next wave!                                                                                 credit: juancap3q Tumblr


If you are in Key West stop by and say hi to me, if I'm not out of town it's likely I'll be at Sloppy Joes or The Schooner Wharf Bar once the sun goes down! I love to make new friends and men please do not be intimidated by my looks, I do not bite! Dance, be happy, enjoy life and good luck in all your trades!

Sierra World Equity Review

Independent and uncompensated! Sierra World Equity Review and it's publisher have never been compensated to promote any stock. We are not affiliated with any executives, owners, brokers, promoters or analysts. The publisher of Sierra World Equity Review is not a registered investment adviser, before making a purchase or sale of any securities featured on this site, we strongly recommend consultation with a registered securities representative. Please remember to do your own due diligence in regards to any stocks that appear on our websites, never trade securities based on Sierra's speculations or predictions! Please read our disclaimer and privacy policy below.

Interpace Diagnostics Group (IDXG) and Johnson & Johnson (JNJ) extend buyout discussions through weekend at The Heldrich Hotel and Conference Center in New Brunswick predicts Sierra World Equity Review.

Interpace Diagnostics Group (IDXG) and Johnson & Johnson (JNJ) extend buyout discussions through weekend at The Heldrich Hotel and Conference Center in New Brunswick predicts Sierra World Equity Review. Shares of IDGX were sharply higher up 33% at the end of Friday's session. Sierra's colleague Natashsa has checked into the hotel for the weekend and will be working her sources to get the latest. Watch for breaking news, remember when it happens Sierra told you first!

Most of our publisher picks rise 100%, 200% or more once they hit the front page of our blog. Get some, sit back and enjoy the ride! 

**Our Latest Publisher Pick is  Pegasus Pharmaceuticals (PGUZ), the most undervalued biotech stock out there**


With over 1.5 million visitors to our blogs and thousands of visitors daily, Sierra World Equity Review will be giving MASSIVE MULTIPLE DAY targeted audience exposure to our latest Publisher Alert: Pegasus Pharmaceuticals (PGUZ)



Here is why our Publisher has initiated a  position in Pegasus Pharmaceuticals (PGUZ)

My NEW Pick is Pegasus Pharmaceuticals (PGUZ). It's cutting edge patented technology named the HeartVue™ 6S System allows for the non-invasive screening of heart disease. Incredibly the technology provides a 3d portrait of the heart in just 60 seconds. This is a huge game changer and the CEO has confirmed that they are now working with some big pharmaceutical companies,  2 are believed to be German based Bayer AG and US based Bristol Meyers-Squibb (BMY), both who have invested heavily in non-invasive screening for heart pathologies. With marketing already happening in Europe the company now has filed with the FDA for approval in the US. This stock is under the radar trading sub penny but that won't last long, the CEO has hinted at big news and stated he will be providing updates shortly, NOW is the time to buy before this tiny biotech gets discovered, they could become the biggest gainer of 2016!




My NEW Pick is a small biotech company called Pegasus Pharmaceuticals (PGUZ). They look like they could become the biggest gainer of the year, trading now in sub-penny range but likely to ink a partnership or even be acquired by one of the two big pharmaceutical company they are currently working with. Now is the time to buy shares of PGUZ, don't get left behind!

Pegasus Pharmaceuticals (PGUZ)  Highlights:

- An amazing share structure of just 21.6M O/S
- A float of just 5M
- Insiders own over half the float and they are NOT SELLING
-Patented game changing, revenue generating cutting edge technology that is desired by big Pharma
-CEO confirmed the company is working with some big Pharma's ( 2 of which are believed to be German based Bayer AG and US based Bristol Meyers-Squibb (BMY)
-Massive revenue potential, considering that in the US alone annually, approximately 635,000 Americans experience a new coronary event, 280,000 have a recurrent ischemic event, and an additional 150,000 have a silent first myocardial infarction. The ability to easily diagnosis heart disease will not only save countless lives but be incredibly lucrative, especially since the technology is patented by Pegasus Pharmaceuticals (PGUZ)


About Pegasus Pharmaceuticals (PGUZ)  

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities


***BE FIRST TO RECEIVE DarthTraderWins WINNING PICKS ON TWITTER***



About Sierra

Hi, my name is Sierra and I'm 27 yrs old. I'm single and I live in Old Town in beautiful Key West, Florida. Thanks to a family inheritance I feel very blessed and fortunate to be financially independent allowing me to live life to the fullest!
Apart from the stock market my favorite things to do are mostly beach related, I love surfing and spend months of the year travelling to different surfing hot spots worldwide chasing the next big wave. When I'm not in the water you can find me playing beach volleyball, enjoying happy hour with friends or dancing the night away! 

Paddling out for the next wave!                                                                                 credit: juancap3q Tumblr


If you are in Key West stop by and say hi to me, if I'm not out of town it's likely I'll be at Sloppy Joes or The Schooner Wharf Bar once the sun goes down! I love to make new friends and men please do not be intimidated by my looks, I do not bite! Dance, be happy, enjoy life and good luck in all your trades!

Sierra World Equity Review

Independent and uncompensated! Sierra World Equity Review and it's publisher have never been compensated to promote any stock. We are not affiliated with any executives, owners, brokers, promoters or analysts. The publisher of Sierra World Equity Review is not a registered investment adviser, before making a purchase or sale of any securities featured on this site, we strongly recommend consultation with a registered securities representative. Please remember to do your own due diligence in regards to any stocks that appear on our websites, never trade securities based on Sierra's speculations or predictions! Please read our disclaimer and privacy policy below.

Thursday, December 8, 2016

My NEW Pick is Pegasus Pharmaceuticals (PGUZ). It's cutting edge patented technology named the HeartVue™ 6S System allows for the non-invasive screening of heart disease. Incredibly the technology provides a 3d portrait of the heart in just 60 seconds. This is a huge game changer and the CEO has confirmed that they are now working with some big pharmaceutical companies, 2 are believed to be German based Bayer AG and US based Bristol Meyers-Squibb (BMY), both who have invested heavily in non-invasive screening for heart pathologies. With marketing already happening in Europe the company now has filed with the FDA for approval in the US. This stock is under the radar trading sub penny but that won't last long, the CEO has hinted at big news and stated he will be providing updates shortly, NOW is the time to buy before this tiny biotech gets discovered, they could become the biggest gainer of 2016!

Interpace Diagnostics Group (IDXG) and Johnson & Johnson (JNJ) extend buyout discussions through weekend at The Heldrich Hotel and Conference Center in New Brunswick predicts Sierra World Equity Review. Shares of IDGX were sharply higher up 33% at the end of Friday's session. Sierra's colleague Natashsa has checked into the hotel for the weekend and will be working her sources to get the latest. Watch for breaking news, remember when it happens Sierra told you first!

Most of our publisher picks rise 100%, 200% or more once they hit the front page of our blog. Get some, sit back and enjoy the ride! 


**My Latest Publisher Pick is  Pegasus Pharmaceuticals (PGUZ)**

My NEW Pick is Pegasus Pharmaceuticals (PGUZ). It's cutting edge patented technology named the HeartVue™ 6S System allows for the non-invasive screening of heart disease. Incredibly the technology provides a 3d portrait of the heart in just 60 seconds. This is a huge game changer and the CEO has confirmed that they are now working with some big pharmaceutical companies,  2 are believed to be German based Bayer AG and US based Bristol Meyers-Squibb (BMY), both who have invested heavily in non-invasive screening for heart pathologies. With marketing already happening in Europe the company now has filed with the FDA for approval in the US. This stock is under the radar trading sub penny but that won't last long, the CEO has hinted at big news and stated he will be providing updates shortly, NOW is the time to buy before this tiny biotech gets discovered, they could become the biggest gainer of 2016!


DarthTraderWins produces WINNERS, since November 2016 NONE of my picks have never lost, Pegasus Pharmaceuticals (PGUZ) will be BIG WINNER number 8 in row, do not get left behind!

11/10/2016 our first pick Liberty Coal and Energy (LBTG) rose 200% in one day11/16/2016 our second pick SpectraScience (SCIE) gained 60% in one day
11/18/2016 our third pick Hybrid Coating Tech. (HCTI) soared over 100% in 2 days
11/23/2016 our fourth pick Blue Star Opportunities (BSTO) gained 200% over 5 days
11/25/2016 our fifth pick Giggles N' Hugs (GIGL) rose 158% over 2 days
11/25/2016 our sixth FullCircle Registry (FLCR) gained over 53% in 6 days
12/01/2016 our seventh pick Zann Corp, (ZNNC) gained 140% in 7 days

***BE FIRST TO RECEIVE DarthTraderWins WINNING PICKS ON TWITTER***


My NEW Pick is a small biotech company called Pegasus Pharmaceuticals (PGUZ). They look like they could become the biggest gainer of the year, trading now in sub-penny range but likely to ink a partnership or even be acquired by one of the two big pharmaceutical company they are currently working with. Now is the time to buy shares of PGUZ, don't get left behind!

Pegasus Pharmaceuticals (PGUZ)  Highlights:

- An amazing share structure of just 21.6M O/S
- A float of just 5M
- Insiders own over half the float and they are NOT SELLING
-Patented game changing, revenue generating cutting edge technology that is desired by big Pharma
-CEO confirmed the company is working with some big Pharma's ( 2 of which are believed to be German based Bayer AG and US based Bristol Meyers-Squibb (BMY)
-Massive revenue potential, considering that in the US alone annually, approximately 635,000 Americans experience a new coronary event, 280,000 have a recurrent ischemic event, and an additional 150,000 have a silent first myocardial infarction. The ability to easily diagnosis heart disease will not only save countless lives but be incredibly lucrative, especially since the technology is patented by Pegasus Pharmaceuticals (PGUZ)


About Pegasus Pharmaceuticals (PGUZ)  

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities



About DarthTraderWins

DarthTraderWins tracks daily short sales data and analyses stock fundamentals to find undervalued stock picks.
I produce WINNERS, since November 2016 NONE of my picks have EVER lost, don't ever get left behind again!







DarthTraderWins and it's publisher have never been compensated to promote any stock. We are not affiliated with any executives, owners, brokers, promoters or analysts. The publisher of DarthTraderWins is not a registered investment adviser, before making a purchase or sale of any securities featured on this site, we strongly recommend consultation with a registered securities representative. Please remember to do your own due diligence in regards to any stocks that appear on our websites, never trade securities based on DarthTraderWins speculations or predictions! Please read our disclaimer and privacy policy below.
***BE FIRST TO RECEIVE DarthTraderWins WINNING PICKS ON TWITTER***



About Sierra

Hi, my name is Sierra and I'm 27 yrs old. I'm single and I live in Old Town in beautiful Key West, Florida. Thanks to a family inheritance I feel very blessed and fortunate to be financially independent allowing me to live life to the fullest!
Apart from the stock market my favorite things to do are mostly beach related, I love surfing and spend months of the year travelling to different surfing hot spots worldwide chasing the next big wave. When I'm not in the water you can find me playing beach volleyball, enjoying happy hour with friends or dancing the night away! 

Paddling out for the next wave!                                                                                 credit: juancap3q Tumblr


If you are in Key West stop by and say hi to me, if I'm not out of town it's likely I'll be at Sloppy Joes or The Schooner Wharf Bar once the sun goes down! I love to make new friends and men please do not be intimidated by my looks, I do not bite! Dance, be happy, enjoy life and good luck in all your trades!

Sierra World Equity Review

Independent and uncompensated! Sierra World Equity Review and it's publisher have never been compensated to promote any stock. We are not affiliated with any executives, owners, brokers, promoters or analysts. The publisher of Sierra World Equity Review is not a registered investment adviser, before making a purchase or sale of any securities featured on this site, we strongly recommend consultation with a registered securities representative. Please remember to do your own due diligence in regards to any stocks that appear on our websites, never trade securities based on Sierra's speculations or predictions! Please read our disclaimer and privacy policy below.

Wednesday, December 7, 2016

ON4 COMMUNICATIONS (ONCI) to announce new joint venture for FMS Drive Safe App with Japanese based Zann Corp (ZNNC) predicts Sierra World Equity Review

ON4 COMMUNICATIONS (ONCI) to announce new joint venture for FMS Drive Safe App with Japanese based Zann Corp (ZNNC) predicts Sierra World Equity Review. Watch for breaking news, when it happens remember you heard it here first! Shares of ONCI were trading lower down 20 % during Wednesday's regular trading session, while ZNNC shares were beginning to break out up 25%. 


Most of our publisher picks rise 100%, 200% or more once they hit the front page of our blog. Get some, sit back and enjoy the ride! 

**Our Latest Publisher Pick is  Pegasus Pharmaceuticals (PGUZ)**

My NEW Pick is Pegasus Pharmaceuticals (PGUZ). It's cutting edge patented technology named the HeartVue™ 6S System allows for the non-invasive screening of heart disease. Incredibly the technology provides a 3d portrait of the heart in just 60 seconds. This is a huge game changer and the CEO has confirmed that they are now working with some big pharmaceutical companies,  2 are believed to be German based Bayer AG and US based Bristol Meyers-Squibb (BMY), both who have invested heavily in non-invasive screening for heart pathologies. With marketing already happening in Europe the company now has filed with the FDA for approval in the US. This stock is under the radar trading sub penny but that won't last long, the CEO has hinted at big news and stated he will be providing updates shortly, NOW is the time to buy before this tiny biotech gets discovered, they could become the biggest gainer of 2016!


DarthTraderWins produces WINNERS, since November 2016 NONE of my picks have never lost, Pegasus Pharmaceuticals (PGUZ) will be BIG WINNER number 8 in row, do not get left behind!

11/10/2016 our first pick Liberty Coal and Energy (LBTG) rose 200% in one day11/16/2016 our second pick SpectraScience (SCIE) gained 60% in one day
11/18/2016 our third pick Hybrid Coating Tech. (HCTI) soared over 100% in 2 days
11/23/2016 our fourth pick Blue Star Opportunities (BSTO) gained 200% over 5 days
11/25/2016 our fifth pick Giggles N' Hugs (GIGL) rose 158% over 2 days
11/25/2016 our sixth FullCircle Registry (FLCR) gained over 53% in 6 days
12/01/2016 our seventh pick Zann Corp, (ZNNC) gained 140% in 7 days

***BE FIRST TO RECEIVE DarthTraderWins WINNING PICKS ON TWITTER***


My NEW Pick is a small biotech company called Pegasus Pharmaceuticals (PGUZ). They look like they could become the biggest gainer of the year, trading now in sub-penny range but likely to ink a partnership or even be acquired by one of the two big pharmaceutical company they are currently working with. Now is the time to buy shares of PGUZ, don't get left behind!

Pegasus Pharmaceuticals (PGUZ)  Highlights:

- An amazing share structure of just 21.6M O/S
- A float of just 5M
- Insiders own over half the float and they are NOT SELLING
-Patented game changing, revenue generating cutting edge technology that is desired by big Pharma
-CEO confirmed the company is working with some big Pharma's ( 2 of which are believed to be German based Bayer AG and US based Bristol Meyers-Squibb (BMY)
-Massive revenue potential, considering that in the US alone annually, approximately 635,000 Americans experience a new coronary event, 280,000 have a recurrent ischemic event, and an additional 150,000 have a silent first myocardial infarction. The ability to easily diagnosis heart disease will not only save countless lives but be incredibly lucrative, especially since the technology is patented by Pegasus Pharmaceuticals (PGUZ)


About Pegasus Pharmaceuticals (PGUZ)  

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities



About DarthTraderWins

DarthTraderWins tracks daily short sales data and analyses stock fundamentals to find undervalued stock picks.
I produce WINNERS, since November 2016 NONE of my picks have EVER lost, don't ever get left behind again!




DarthTraderWins and it's publisher have never been compensated to promote any stock. We are not affiliated with any executives, owners, brokers, promoters or analysts. The publisher of DarthTraderWins is not a registered investment adviser, before making a purchase or sale of any securities featured on this site, we strongly recommend consultation with a registered securities representative. Please remember to do your own due diligence in regards to any stocks that appear on our websites, never trade securities based on DarthTraderWins speculations or predictions! Please read our disclaimer and privacy policy below.
***BE FIRST TO RECEIVE DarthTraderWins WINNING PICKS ON TWITTER***


About Sierra

Hi, my name is Sierra and I'm 27 yrs old. I'm single and I live in Old Town in beautiful Key West, Florida. Thanks to a family inheritance I feel very blessed and fortunate to be financially independent allowing me to live life to the fullest!
Apart from the stock market my favorite things to do are mostly beach related, I love surfing and spend months of the year travelling to different surfing hot spots worldwide chasing the next big wave. When I'm not in the water you can find me playing beach volleyball, enjoying happy hour with friends or dancing the night away! 

Paddling out for the next wave!                                                                                 credit: juancap3q Tumblr


If you are in Key West stop by and say hi to me, if I'm not out of town it's likely I'll be at Sloppy Joes or The Schooner Wharf Bar once the sun goes down! I love to make new friends and men please do not be intimidated by my looks, I do not bite! Dance, be happy, enjoy life and good luck in all your trades!

Sierra World Equity Review

Independent and uncompensated! Sierra World Equity Review and it's publisher have never been compensated to promote any stock. We are not affiliated with any executives, owners, brokers, promoters or analysts. The publisher of Sierra World Equity Review is not a registered investment adviser, before making a purchase or sale of any securities featured on this site, we strongly recommend consultation with a registered securities representative. Please remember to do your own due diligence in regards to any stocks that appear on our websites, never trade securities based on Sierra's speculations or predictions! Please read our disclaimer and privacy policy below.